A Phase 1 Study of SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid Tumors

Condition:   Solid Tumor Interventions:   Drug: SAIL66;   Drug: Tocilizumab Sponsor:   Chugai Pharmaceutical Not yet recruiting

Source: ClinicalTrials.gov - February 21, 2023 Category: Research Source Type: clinical trials